Literature DB >> 17686212

Increasing rates of community-acquired methicillin-resistant Staphylococcus aureus infections among HIV-infected persons.

Nancy F Crum-Cianflone1, Alina A Burgi, Braden R Hale.   

Abstract

Community-acquired (CA) methicillin-resistant Staphylococcus aureus (MRSA) rates have rapidly increased in the general population; however, little data on recent incidence rates and risk factors of CA-MRSA infections among HIV patients appear in the literature. A retrospective study was conducted from 1993 through 2005 among patients at a large HIV clinic. Trends in CA-MRSA infection incidence rates, clinical characteristics and risk factors for CA-MRSA were evaluated. Seven percent of our cohort developed a CA-MRSA infection during the study period. The rate of CA-MRSA infections among HIV-infected population significantly increased since 2003, with an incidence of 40.3 cases/1000 person-years in 2005, which was 18-fold higher than the general population served at our facility. In all, 90% of infections were skin/soft tissue infections with a predilection for buttock or scrotal abscess formation; 21% of patients experienced a recurrent infection. Risk factors included a low CD4 count at the time of infection (odds ratio [OR] per 100 CD4 cells 0.84, P = 0.03), high maximum log(10) HIV viral load (OR 4.54, P<0.001), recent use of beta-lactam antibiotics (OR 6.0 for receipt of two prescriptions, P<0.001) and a history of syphilis (OR 4.55, P = 0.01). No patient receiving trimethoprim-sulfamethoxazole prophylaxis developed a CA-MRSA infection. Over the study period, CA-MRSA accounted for an increasing percentage of positive wound cultures and Staphylococcus aureus isolates, 37% and 65%, respectively, during 2005. In conclusion, CA-MRSA infections have rapidly increased among HIV-infected patients, a group which has a higher rate of these infections than the general population. Risk factors for CA-MRSA among HIV-infected patients include low current CD4 cell count, recent beta-lactam antibiotic use and potentially high-risk sexual activity as demonstrated by a history of syphilis infection.

Entities:  

Mesh:

Year:  2007        PMID: 17686212     DOI: 10.1258/095646207781439702

Source DB:  PubMed          Journal:  Int J STD AIDS        ISSN: 0956-4624            Impact factor:   1.359


  45 in total

1.  High prevalence of colonization with Staphylococcus aureus clone USA300 at multiple body sites among sexually transmitted disease clinic patients: an unrecognized reservoir.

Authors:  Benjamin A Miko; Anne-Catrin Uhlemann; Amanda Gelman; Caroline J Lee; Cory A Hafer; Sean B Sullivan; Qiuhu Shi; Maureen Miller; Jonathan Zenilman; Franklin D Lowy
Journal:  Microbes Infect       Date:  2012-06-21       Impact factor: 2.700

Review 2.  HIV-Related Skin Disease in the Era of Antiretroviral Therapy: Recognition and Management.

Authors:  Khatiya Chelidze; Cristina Thomas; Aileen Yenting Chang; Esther Ellen Freeman
Journal:  Am J Clin Dermatol       Date:  2019-06       Impact factor: 7.403

Review 3.  Severe necrotizing fasciitis in a human immunodeficiency virus-positive patient caused by methicillin-resistant Staphylococcus aureus.

Authors:  Randall J Olsen; Kevin M Burns; Liang Chen; Barry N Kreiswirth; James M Musser
Journal:  J Clin Microbiol       Date:  2008-01-16       Impact factor: 5.948

4.  Necrotizing pneumonia caused by community-acquired methicillin-resistant Staphylococcus aureus: an increasing cause of "mayhem in the lung".

Authors:  Mark D Ebert; Sheila Sheth; Elliot K Fishman
Journal:  Emerg Radiol       Date:  2008-02-15

5.  Guidelines for the prevention and treatment of opportunistic infections in HIV-exposed and HIV-infected children: recommendations from the National Institutes of Health, Centers for Disease Control and Prevention, the HIV Medicine Association of the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the American Academy of Pediatrics.

Authors:  George K Siberry; Mark J Abzug; Sharon Nachman; Michael T Brady; Kenneth L Dominguez; Edward Handelsman; Lynne M Mofenson; Steve Nesheim
Journal:  Pediatr Infect Dis J       Date:  2013-11       Impact factor: 2.129

6.  Prevalence and risk factors for methicillin-resistant Staphylococcus aureus in an HIV-positive cohort.

Authors:  Jason E Farley; Matthew J Hayat; Paul L Sacamano; Tracy Ross; Karen Carroll
Journal:  Am J Infect Control       Date:  2015-02-14       Impact factor: 2.918

7.  Short communication: methicillin-resistant Staphylococcus aureus infections in children and young adults infected with HIV.

Authors:  Ashok Srinivasan; Steven Seifried; Liang Zhu; Wally Bitar; Deo K Srivastava; Jerry L Shenep; Matthew J Bankowski; Patricia M Flynn; Randall T Hayden
Journal:  AIDS Res Hum Retroviruses       Date:  2009-12       Impact factor: 2.205

8.  Skin and soft tissue infections among HIV-infected persons in the late combination antiretroviral therapy era.

Authors:  N F Crum-Cianflone; G Grandits; A Weintrob; A Ganesan; B Agan; M Landrum
Journal:  Int J STD AIDS       Date:  2012-07       Impact factor: 1.359

9.  Identification of Staphylococcus aureus: DNase and Mannitol salt agar improve the efficiency of the tube coagulase test.

Authors:  David P Kateete; Cyrus N Kimani; Fred A Katabazi; Alfred Okeng; Moses S Okee; Ann Nanteza; Moses L Joloba; Florence C Najjuka
Journal:  Ann Clin Microbiol Antimicrob       Date:  2010-08-13       Impact factor: 3.944

10.  A novel nitroreductase of Staphylococcus aureus with S-nitrosoglutathione reductase activity.

Authors:  Ana Filipa N Tavares; Lígia S Nobre; Ana M P Melo; Lígia M Saraiva
Journal:  J Bacteriol       Date:  2009-03-13       Impact factor: 3.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.